Daiichi Sankyo FY20 Profit Down; Sees Higher Operating Profit, Revenues In FY21

Daiichi Sankyo Co. Ltd. (DSKYF.PK), a Japanese pharmaceutical company, reported Tuesday that its fiscal 2020 profit attributable to owners of the company declined 41.2 percent to 75.96 billion yen from the prior year's 129.07 billion yen. Earnings per share fell to 39.11 yen from 66.27 yen last year.

Operating profit declined 54 percent year on year to 63.80 billion yen.

Revenue for the period dropped 2 percent to 962.52 billion yen from last year's 981.79 billion yen.

Looking ahead for fiscal 2021, the company expects attributable profit of 50 billion yen or 26.09 yen, down 34.2 percent year-over-year. Operating profit is expected to be 70 billion yen, up 9.7 percent, while core operating profit would be down 11.2 percent to 70 billion yen.

Revenue for the year is estimated to be 990 billion yen, up 2.9 percent from the previous year.

In Japan, Daiichi Sankyo shares traded at 2,905 yen, down 3.5 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing. Twitter, Inc. (TWTR) announced Monday that it has entered into a binding agreement to settle the consolidated class action lawsuit commenced in 2016 in the United States District Court for the Northern District of California. Under the terms of the proposed settlement, Twitter will pay $809.5 million... Drug major Pfizer has again expanded the earlier two recalls of its anti-smoking Drug Chantix (Varenicline) in the form of tablets, to now include all the lots, for the potential presence of nitrosamine impurity, N-Nitroso- varenicline, at or above the FDA interim acceptable intake limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement.
Follow RTT